Clearly, future studies are needed to interrogate the function of p38 and ERK1/2 crosstalk in GPCR-induced endothelial dysfunction and the role of the p38-regulated α-catenin S652 phosphorylation in endothelial barrier disruption. The gene discussed is MAPK3; the disease is endothelial dysfunction.